Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial

2023/01/04 by Michael Chu, Michael W.A. Chu, Marc Ruel +73 · 1 voice · 12 citations
Medicine · Engineering · #Cardiac Valve Diseases and Treatments #Atrial Fibrillation Management and Outcomes #Mechanical Circulatory Support Devices

paper · pdf · doi:10.1016/j.athoracsur.2022.12.031

Cited by

• Modern Treatment of Valvulopathies in Patients with Congenital Hemophilia. [europepmc]
• Mitral valve replacement in young patients: review and current challenges. [europepmc]
• Mechanical Valves: Past, Present, and Future-A Review. [europepmc]
• Tissue versus mechanical mitral valve replacement in patients aged 50-70: a propensity-matched analysis. [europepmc]
• Optimizing Anticoagulation in Valvular Heart Disease: Navigating NOACs and VKAs. [europepmc]
• Mid-term outcomes of the COMMENCE trial investigating mitral valve replacement using a bioprosthesis with a novel tissue. [europepmc]
• Classification of kinesiophobia in patients after cardiac surgery under extracorporeal circulation in China: latent profile and influencing factors analysis from a cross-sectional study. [europepmc]
• Society of cardiothoracic surgery in great Britain and Ireland guidance for adult mitral valve disease and interventions. [europepmc]
• Advantages of FVIII-Extended Half-Life (Turoctocog Alfa Pegol) in the Management of Cardiac Surgery in a Patient with Mild Hemophilia A: A Case Report and Literature Review. [europepmc]
• Retrospective Analysis of Therapeutic Modalities in Prosthetic Heart Valve Thrombosis: A 15-Year Single-Center Experience. [europepmc]
• A "Watchful Surgery" Approach: Timing and Valve Choice for Mildly Symptomatic Mitral and Aortic Valve Disease. [europepmc]
• Research on rheumatic heart disease from 2013 to early 2024: a bibliometric analysis. [europepmc]

Discussions

• Warfarin dose in this study seems very similar in outcomes but does not meet non inferiority. Why? [lemmy, 21 points, 3 comments]